相似文献
1
Investigational PET tracers in neuro-oncology-What's on the horizon? A report of the PET/RANO group.
Neuro Oncol. 2022 Nov 2;24(11):1815-1826. doi: 10.1093/neuonc/noac131.
2
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
3
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.
Neuro Oncol. 2016 Sep;18(9):1199-208. doi: 10.1093/neuonc/now058. Epub 2016 Apr 21.
4
Molecular imaging (PET) of brain tumors.
Neuroimaging Clin N Am. 2009 Nov;19(4):625-46. doi: 10.1016/j.nic.2009.08.012.
5
Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group.
Neuro Oncol. 2024 Jul 5;26(7):1181-1194. doi: 10.1093/neuonc/noae049.
7
New PET radiopharmaceuticals beyond FDG for brain tumor imaging.
Q J Nucl Med Mol Imaging. 2012 Apr;56(2):173-90.
8
New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
Eur Urol. 2016 Jul;70(1):161-175. doi: 10.1016/j.eururo.2016.01.029. Epub 2016 Feb 2.
9
Imaging of amino acid transport in brain tumours: Positron emission tomography with O-(2-[F]fluoroethyl)-L-tyrosine (FET).
Methods. 2017 Nov 1;130:124-134. doi: 10.1016/j.ymeth.2017.05.019. Epub 2017 May 24.
10
Role of amino-tracer PET for decision-making in neuro-oncology.
Curr Opin Neurol. 2018 Dec;31(6):720-726. doi: 10.1097/WCO.0000000000000616.
引用本文的文献
1
PSMA-targeted PET imaging for brain metastases from non-prostatic solid tumors: a systematic review.
Front Oncol. 2025 Mar 17;15:1553505. doi: 10.3389/fonc.2025.1553505. eCollection 2025.
2
Tryptophan Kynurenine Pathway-Based Imaging Agents for Brain Disorders and Oncology-From Bench to Bedside.
Biomolecules. 2025 Jan 1;15(1):47. doi: 10.3390/biom15010047.
3
Theranostics and molecular imaging in neuro-oncology: The beginning of a new era.
Neuro Oncol. 2024 Dec 9;26(Supplement_9):S183-S184. doi: 10.1093/neuonc/noae191.
4
[Ga]Ga-FAPI PET/CT in brain tumors: comparison with [F]F-FDG PET/CT.
Front Oncol. 2024 Sep 6;14:1436009. doi: 10.3389/fonc.2024.1436009. eCollection 2024.
5
PET imaging of gliomas: Status quo and quo vadis?
Neuro Oncol. 2024 Dec 9;26(Supplement_9):S185-S198. doi: 10.1093/neuonc/noae078.
6
Glioma.
Nat Rev Dis Primers. 2024 May 9;10(1):33. doi: 10.1038/s41572-024-00516-y.
7
Introducing the American Society of Neuroradiology PET-Guided Diagnosis and Management in Neuro-Oncology Study Group.
AJNR Am J Neuroradiol. 2024 May 9;45(5):535-536. doi: 10.3174/ajnr.A8243.
8
Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group.
Neuro Oncol. 2024 Jul 5;26(7):1181-1194. doi: 10.1093/neuonc/noae049.
9
Introduction to the Special Issue on "Role of Novel Imaging Technique in Brain Tumors".
Cancers (Basel). 2024 Jan 30;16(3):575. doi: 10.3390/cancers16030575.
10
The Traumatic Inoculation Process Affects TSPO Radioligand Uptake in Experimental Orthotopic Glioblastoma.
Biomedicines. 2024 Jan 15;12(1):188. doi: 10.3390/biomedicines12010188.
本文引用的文献
1
Visualizing T-Cell Responses: The T-Cell PET Imaging Toolbox.
J Nucl Med. 2022 Feb;63(2):183-188. doi: 10.2967/jnumed.121.261976. Epub 2021 Dec 9.
2
Multimodal therapy of cavernous sinus meningioma: Impact of surgery and Ga-DOTATATE PET-guided radiation therapy on tumor control and functional outcome.
Neurooncol Adv. 2021 Aug 20;3(1):vdab114. doi: 10.1093/noajnl/vdab114. eCollection 2021 Jan-Dec.
3
F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study.
J Nucl Med. 2022 Jun;63(6):899-905. doi: 10.2967/jnumed.121.262368. Epub 2021 Sep 9.
4
Study of Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non-Small Cell Lung Cancer.
J Nucl Med. 2022 Mar;63(3):362-367. doi: 10.2967/jnumed.121.261926. Epub 2021 Jul 16.
5
PSMA Expression in 122 Treatment Naive Glioma Patients Related to Tumor Metabolism in C-Methionine PET and Survival.
J Pers Med. 2021 Jun 30;11(7):624. doi: 10.3390/jpm11070624.
6
Multimodal evaluation of hypoxia in brain metastases of lung cancer and interest of hypoxia image-guided radiotherapy.
Sci Rep. 2021 May 27;11(1):11239. doi: 10.1038/s41598-021-90662-0.
7
Simultaneous Mapping of Vasculature, Hypoxia, and Proliferation Using Dynamic Susceptibility Contrast MRI, F-FMISO PET, and F-FLT PET in Relation to Contrast Enhancement in Newly Diagnosed Glioblastoma.
J Nucl Med. 2021 Oct;62(10):1349-1356. doi: 10.2967/jnumed.120.249524. Epub 2021 May 20.
8
Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET.
Clin Cancer Res. 2021 Jul 1;27(13):3704-3713. doi: 10.1158/1078-0432.CCR-21-0471. Epub 2021 May 4.
9
Imaging of T-cell Responses in the Context of Cancer Immunotherapy.
Cancer Immunol Res. 2021 May;9(5):490-502. doi: 10.1158/2326-6066.CIR-20-0678.
10
PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET Imaging.
Front Oncol. 2021 Mar 30;11:646387. doi: 10.3389/fonc.2021.646387. eCollection 2021.
Zotero 插件